BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30066881)

  • 1. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
    Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
    Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
    PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y
    BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival.
    Xi HQ; Wu XS; Wei B; Chen L
    J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22350700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
    Zhou J; Wu A; Yu X; Zhu J; Dai H
    Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
    Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3).
    Zhang S; Zhang R; Xu R; Shang J; He H; Yang Q
    Gene; 2020 Apr; 733():144383. PubMed ID: 31972307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-1228
    Jia L; Chen J; Xie C; Shao L; Xu Z; Zhang L
    Life Sci; 2017 Jul; 180():9-16. PubMed ID: 28465246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
    Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
    Liang W; Xia B; He C; Zhai G; Li M; Zhou J
    Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.